US judge to approve Purdue Pharma's opioid bankruptcy settlement
A federal bankruptcy judge said on Friday he will approve a restructuring plan for drugmaker Purdue Pharma that includes a $7.4 billion settlement.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.